Domestic Hematology Analyzer Market Size Rose by 0.9% to Achieve 573200 Million Yen in 2018
Yano Research Institute (the President, Takashi Mizukoshi) has conducted a survey on the domestic hematology analyzer market and has found out the trends by product item, the trend of market players, and the future perspectives.
Hematology analyzers in this research indicate the following nine categories: 1) Automated biochemical analyzers that conduct biochemical tests out of specimen inspection devices, 2) Dry chemistry systems, 3) Electrolyte analyzers, 4) Glucose analyzers, 5) Blood gas analyzers for physiological tests, 6) Blood cell counters for hematologic tests, 7) Blood coagulation analyzers, 8) Immunological analyzers, and 9) Glycated hemoglobin analyzers (high performance liquid chromatograph).
The domestic hematology analyzers market for 2018 (the total 9 types of hematology analyzers based on the shipment values at manufacturers) rose by 0.9% from the previous year to attain 57,320 million yen. All the types of hematology analyzers generally have slowed down to remain the same level as the previous year, now that the demand for those analyzers have come to be that of replacement, after their wide acceptance at hospitals, medical facilities and inspection centers, and as the number of hospitals decreasing. While the market size has kept being the same level, immunological analyzers have expanded the sales due to increasing implementation of inspections and to coping with newly adopted markers.
The advantage of automated biochemical analyzers is that a single such analyzer can carry out multiple inspections across various categories, as they have come to equip with inspection functions one after another in the category of immune serum and hematology. Recently, the development of enzymatic reagents has enabled inspection of many items and categories of biochemicals (enzyme, glucose, and fat), protein, inorganic ion electrolyte, non-protein nitrogen components, blood serum, immunity components, urinary constituent, and etc., encouraging each analyzer maker to develop analyzers for multiple items.
Particularly, immunological analyzers have become integrated into those automated biochemical analyzers and have been adopted extensively, making biochemical tests and immunological tests to progressively be on the same line. The most state-of-the-art analyzer commercialized is the integrated one that has biochemical module available to carry out multiple analysis items to multiple specimens, equipped with an immunological module. From now on, these integrated types of analyzers are expected to be installed at increasing number of facilities, and accelerate their propagation.
The domestic hematology analyzers market for 2019 (the total 9 categories of hematology analyzers based on the shipment values at manufacturers) is expected to rise by1.7% from the previous year to attain 582,700 million yen. Last-minute spending surge is projected just before the consumption tax hike scheduled in 2019, but cannot expect the surge to be as high as the last tax increase in 2014. The market size in 2020 and beyond is likely to remain the same level, as the demand for such analyzers are likely to primarily consists of replacement. The domestic market size is projected to be 58,110 million yen, a rise by 1.4% from 2018.
The copyright and all other rights pertaining to this report belong to Yano Research Institute.
Please contact our PR team when quoting the report contents for the purpose other than media coverage.
Depending on the purpose of using our report, we may ask you to present your sentences for confirmation beforehand.